89 related articles for article (PubMed ID: 25941785)
21. A Gd3Al tetranuclear complex as a potential bimodal MRI/optical imaging agent.
Li WS; Luo J; Jiang F; Chen ZN
Dalton Trans; 2012 Aug; 41(31):9405-10. PubMed ID: 22740063
[TBL] [Abstract][Full Text] [Related]
22. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
[TBL] [Abstract][Full Text] [Related]
23. Gadolinium-based nanoparticles for highly efficient T1-weighted magnetic resonance imaging.
Lim EK; Kang B; Choi Y; Jang E; Han S; Lee K; Suh JS; Haam S; Huh YM
Nanotechnology; 2014 Jun; 25(24):245103. PubMed ID: 24872113
[TBL] [Abstract][Full Text] [Related]
24. Carbon quantum dot stabilized gadolinium nanoprobe prepared via a one-pot hydrothermal approach for magnetic resonance and fluorescence dual-modality bioimaging.
Xu Y; Jia XH; Yin XB; He XW; Zhang YK
Anal Chem; 2014 Dec; 86(24):12122-9. PubMed ID: 25383762
[TBL] [Abstract][Full Text] [Related]
25. How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
Perles-Barbacaru AT; van der Sanden BP; Farion R; Lahrech H
J Cereb Blood Flow Metab; 2012 Mar; 32(3):489-501. PubMed ID: 22068227
[TBL] [Abstract][Full Text] [Related]
26. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
27. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
28. Ultrasmall bimodal nanomolecules enhanced tumor angiogenesis contrast with endothelial cell targeting and molecular pharmacokinetics.
Li X; Wu M; Wang J; Dou Y; Gong X; Liu Y; Guo Q; Zhang X; Chang J; Niu Y
Nanomedicine; 2019 Jan; 15(1):252-263. PubMed ID: 30359756
[TBL] [Abstract][Full Text] [Related]
29. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
[TBL] [Abstract][Full Text] [Related]
30. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
31. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
[TBL] [Abstract][Full Text] [Related]
32. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
Jahanbin T; Sauriat-Dorizon H; Spearman P; Benderbous S; Korri-Youssoufi H
Mater Sci Eng C Mater Biol Appl; 2015; 52():325-32. PubMed ID: 25953574
[TBL] [Abstract][Full Text] [Related]
33. Implementation of P22 viral capsids as intravascular magnetic resonance T1 contrast conjugates via site-selective attachment of Gd(III)-chelating agents.
Min J; Jung H; Shin HH; Cho G; Cho H; Kang S
Biomacromolecules; 2013 Jul; 14(7):2332-9. PubMed ID: 23758486
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral evaluation of 3D microvasculature and nanoparticle distribution using a gadolinium-dendron modified nano-liposomal contrast agent with magnetic resonance micro-imaging.
Nitta N; Takakusagi Y; Kokuryo D; Shibata S; Tomita A; Higashi T; Aoki I; Harada M
Nanomedicine; 2018 Jun; 14(4):1315-1324. PubMed ID: 29626524
[TBL] [Abstract][Full Text] [Related]
35. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
36. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
37. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
[TBL] [Abstract][Full Text] [Related]
38. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents.
Ferrauto G; Delli Castelli D; Di Gregorio E; Langereis S; Burdinski D; Grüll H; Terreno E; Aime S
J Am Chem Soc; 2014 Jan; 136(2):638-41. PubMed ID: 24359116
[TBL] [Abstract][Full Text] [Related]
39. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
